Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

07 August 2002

Epidemiological surveillance of pediatric Hodgkin’s disease in southern Iran

Mehran Karimi, Hooman Yarmohammadi, Ahmad A. Ghavanini, Perikala V. Kumar

Med Sci Monit 2002; 8(8): CR572-575 :: ID: 13600

Abstract

Background: To study the epidemiological pattern of Hodgkin’s disease (HD) in children of Southern Iran, a total of 120 cases of biopsy-proven Hodgkin’s disease, less than 18 years old, submitted for
histological diagnosis during 1987-1997 were classified, using the Rye’s Classification.
Material/Methods: Data on age, sex, number in households, socio-economic status, clinical presentation, signs and symptoms, para-clinical data at the time of diagnosis, treatment plan, recurrence and the presence of metastases were derived from the patients’ history, and analyzed.
Results: The largest subgroups were those of Mixed cellularity (66.7%), followed by Nodular sclerosis (23.3%), Lymphocytic predominance (8.3%) and Lymphocytic depletion (1.7%). The male-tofemale ratio was 2.87. Patients with Nodular sclerosis were generally older than those in other groups. The mean age in all histopathological classes was higher in females.
Conclusion: The epidemiological pattern of the HD in southern Iran is similar to that of other developing countries and the northern part of Iran, in which mixed cellularity is the most common subtype.
However, this pattern differs from the pattern seen in the United State and Europe, since Nodular sclerosis is the most common subtype in these regions.

Keywords: Iran - epidemiology

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

12 Mar 2024 : Clinical Research  

Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...

Med Sci Monit In Press; DOI: 10.12659/MSM.943500  

0:00

12 Mar 2024 : Review article  

Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive Strategies

Med Sci Monit In Press; DOI: 10.12659/MSM.943240  

0:00

12 Mar 2024 : Clinical Research  

Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis

Med Sci Monit In Press; DOI: 10.12659/MSM.943360  

0:00

14 Mar 2024 : Clinical Research  

Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...

Med Sci Monit In Press; DOI: 10.12659/MSM.943956  

0:00

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750